Cloning of novel immunoglobulin superfamily receptors expressed on human myeloid and lymphoid cells: structural evidence for new stimulatory and inhibitory pathways
about
Modulation of Toll-like receptor activity by leukocyte Ig-like receptors and their effects during bacterial infectionMyeloid DAP12-associating lectin (MDL)-1 is a cell surface receptor involved in the activation of myeloid cellsThe MHC class I binding proteins LIR-1 and LIR-2 inhibit Fc receptor-mediated signaling in monocytesNKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamilyIdentification and molecular cloning of p75/AIRM1, a novel member of the sialoadhesin family that functions as an inhibitory receptor in human natural killer cellsMolecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cellsA common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cellsImmunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cellsA novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processingIdentification of a family of Fc receptor homologs with preferential B cell expressionActivation of human eosinophils through leukocyte immunoglobulin-like receptor 7Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cellsA novel member of the leukocyte receptor complex regulates osteoclast differentiationTetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cellsHuman inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-GCrystal structure of the HLA-Cw3 allotype-specific killer cell inhibitory receptor KIR2DL2Crystal Structure of Leukocyte Ig-like Receptor LILRB4 (ILT3/LIR-5/CD85k): A MYELOID INHIBITORY RECEPTOR INVOLVED IN IMMUNE TOLERANCECrystal structures of the two membrane-proximal Ig-like domains (D3D4) of LILRB1/B2: alternative models for their involvement in peptide-HLA bindingCommon polymorphisms and alternative splicing in the ILT3 gene are not associated with atopyAssociation of tyrosine phosphatases SHP-1 and SHP-2, inositol 5-phosphatase SHIP with gp49B1, and chromosomal assignment of the geneIsotypic variation of novel immunoglobulin-like transcript/killer cell inhibitory receptor loci in the leukocyte receptor complexThe carboxyl-terminal region of biliary glycoprotein controls its tyrosine phosphorylation and association with protein-tyrosine phosphatases SHP-1 and SHP-2 in epithelial cellsInhibition of IgE-mediated mast cell activation by the paired Ig-like receptor PIR-BPaired activating and inhibitory immunoglobulin-like receptors, MAIR-I and MAIR-II, regulate mast cell and macrophage activationCharacterization of TREM-3, an activating receptor on mouse macrophages: definition of a family of single Ig domain receptors on mouse chromosome 17The gene encoding the immunoregulatory signaling molecule CMRF-35A localized to human chromosome 17 in close proximity to other members of the CMRF-35 familyIs the CD200/CD200 receptor interaction more than just a myeloid cell inhibitory signal?DAP12-mediated signal transduction in natural killer cells. A dominant role for the Syk protein-tyrosine kinaseCharacterisation of bovine leukocyte Ig-like receptorsMicrobially cleaved immunoglobulins are sensed by the innate immune receptor LILRA2Identification and characterisation of a novel immune-type receptor (NITR) gene cluster in the European sea bass, Dicentrarchus labrax, reveals recurrent gene expansion and diversification by positive selection.Cloning and characterization of a novel mouse myeloid DAP12-associated receptor family.The co-expression of activating and inhibitory leukocyte immunoglobulin-like receptors in rheumatoid synovium.Functional analysis of activating receptor LMIR4 as a counterpart of inhibitory receptor LMIR3.How to extinguish lymphocyte activation, immunotyrosine-based inhibition motif (ITIM)-bearing molecules a solution?KIR genes polymorphism in Argentinean Caucasoid and Amerindian populations.Differential expression of leukocyte immunoglobulin-like receptors on cord-blood-derived human mast cell progenitors and mature mast cells.Association of the LILRA3 deletion with B-NHL and functional characterization of the immunostimulatory molecule.Downregulation of immunoglobulin-like transcript-4 (ILT4) in patients with psoriatic arthritis.Interplay of natural killer cells and their receptors with the adaptive immune response.
P2860
Q21296861-82C79B28-3849-4329-9976-CF6CB63CC293Q22003745-5DB77182-8AC4-437E-B666-2EDA997C1333Q22008474-F836145B-0F75-4867-B9E7-7446251CBDBBQ22008826-8E0C8D28-A55B-40A4-919C-001BEB8270A6Q22010576-6353F435-2D0C-4BF9-9305-2C2C5BB1BDC9Q22010724-6C16768F-3F04-4AC9-A720-49E01A1B651AQ24310017-BA3546EF-170D-410E-A245-4DC28761B2C7Q24315619-36F0FF1B-3447-409A-B9C1-01B837094DCDQ24321561-217AE784-25B2-4908-8AE3-5555B2520D04Q24555760-7F2A24E8-2FBA-463F-99C1-3E3DAC0D9E67Q24597517-F9F23DD2-480E-4E35-9450-0C7DA5E0AD70Q24671834-6260E95F-A5B3-42E0-AB85-7D1C26B20BAEQ24675157-CCAC3D82-9643-4B86-8317-391E325B84BAQ24676756-13984C1C-62AD-4A2F-BEED-30A6FB72ABF7Q24678795-C9E261BB-795C-4ED8-8567-5B69555D845AQ27617783-6E17A06C-F861-4AE9-A981-B02996B1C81AQ27667381-5D488735-3740-4E57-AA91-190983AAD04BQ27679716-F72723AA-BD49-4432-A51C-3047FB35A168Q28143383-70E9391C-2C07-4753-AE2C-92A73E2DDB92Q28258380-DCCCD48C-495A-4EA3-8E72-0041466C87A6Q28292134-69C740F5-7782-44C8-B0EA-A00511D33B84Q28292434-A50256BA-2002-4167-815E-5E904818E2A3Q28360737-9F2A4611-1244-4EFC-905E-64F4DBC5EFFDQ28586601-609DE022-20F1-4C89-89D0-6754E85D1307Q28589523-582B45E8-1BDC-45EE-AA15-FD8C8DAA8B70Q28610385-E5DE9684-FC65-40CB-AC98-2F4131AAED40Q28610462-FDFBB25D-421F-45C8-82F1-1D4033A306F7Q28610866-61566C09-76E5-478F-B8CD-19C08976B67AQ28730806-8C76D64F-F651-42B9-849F-7047C52E21B6Q29400416-616EF3D8-F405-42D4-A66B-C309CA50F4E5Q30496032-B2517238-B55F-4CA0-AFE2-7216117437BDQ30657557-2D14F8BE-128A-4468-A637-138056294027Q30673087-76A36496-BC60-4B52-816F-D58D7B55612DQ31109562-DF486901-1E66-4801-B30B-05CED3A80D86Q33649811-2FA16271-B7B7-4E1B-90D7-A451011D4E6DQ34627802-C9B030E6-8FCF-44ED-BCF8-B6A69DEE4699Q34712852-7FECF8FD-A96E-4C24-9960-EADA5F4511DBQ35074358-FA979684-3FEA-4F05-948A-4AE3536EF1B1Q35133638-A0FF7D46-5556-4B69-95EF-346F8970D1F8Q35904393-4468D37A-A3F5-4077-83D7-A78534E400EA
P2860
Cloning of novel immunoglobulin superfamily receptors expressed on human myeloid and lymphoid cells: structural evidence for new stimulatory and inhibitory pathways
description
1997 nî lūn-bûn
@nan
1997 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի մարտին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Cloning of novel immunoglobuli ...... latory and inhibitory pathways
@ast
Cloning of novel immunoglobuli ...... latory and inhibitory pathways
@en
Cloning of novel immunoglobuli ...... latory and inhibitory pathways
@en-gb
Cloning of novel immunoglobuli ...... latory and inhibitory pathways
@nl
type
label
Cloning of novel immunoglobuli ...... latory and inhibitory pathways
@ast
Cloning of novel immunoglobuli ...... latory and inhibitory pathways
@en
Cloning of novel immunoglobuli ...... latory and inhibitory pathways
@en-gb
Cloning of novel immunoglobuli ...... latory and inhibitory pathways
@nl
prefLabel
Cloning of novel immunoglobuli ...... latory and inhibitory pathways
@ast
Cloning of novel immunoglobuli ...... latory and inhibitory pathways
@en
Cloning of novel immunoglobuli ...... latory and inhibitory pathways
@en-gb
Cloning of novel immunoglobuli ...... latory and inhibitory pathways
@nl
P356
P1476
Cloning of novel immunoglobuli ...... latory and inhibitory pathways
@en
P2093
J Samaridis
P356
10.1002/EJI.1830270313
P407
P577
1997-03-01T00:00:00Z